JASPI

NARRATIVE REVIEW Smart Prescribing: Utilizing Artificial Intelligence to Minimize Unnecessary Antimicrobial Use in the Emergency Department Swathi Gurajala* JASPI September 2025 / Volume 3/Issue 3 Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the […]

ORIGINAL ARTICLE MICs of Ciprofloxacin, Cefuroxime, and Amikacin among Escherichia coli Urinary Isolates: An AMR Study Harsha Vardhan1, Madhavi Eerike*, Raja S, Nikhila kondampati, Jaideep C K JASPI September 2025 / Volume 3/Issue 3 Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted

ORIGINAL ARTICLE Short-Term Assessment of Knowledge and Practices on Needle-Stick Injury Management among Healthcare Workers: An Educational Intervention Study H. Larikyrpang Kharchandy, Arghya Das, Rahul Garg, Ravindra Singh, Pradyot Prakash JASPI September 2025 / Volume 3/Issue 3 Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License,

Abstract 001                                                               ASPICON 2025 |September 04 -07 | 2025                                                                                                                                                                        To Analyze the Performance of Galactomannan Antigen Detection Assay in Cases of Clinically Suspected

Post-Mortem Sepsis and Post-Mortem Diagnostic Anti-Microbial Stewardship Eeshan Pawar, Aswini Chandran, Diksha Chhabra, Arneet Arora, Sagar Khadanga* JASPI September 2025 / Volume 3 /Issue 3 Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the

Anti-Parasitic Stewardship: An Update in the Indian Setting Aditya Kundu, Ujjala Ghoshal* JASPI September 2025 / Volume 3 /Issue 3 Copyright: © Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are

Other specific DSP article suggested by Editorial Board Ethical use of AI in infectious diagnostic decision and therapeutic stewardship. DOI: 10.1016/j.idcr.2025.e02356 Authors: Panda PK et al   Abstract   Artificial intelligence (AI) is rapidly reshaping healthcare, offering transformative potential in infectious diagnostics and antimicrobial stewardship through enhanced accuracy, efficiency, and predictive capabilities. However, its integration into

Volume 3| Issue 3| July-September 2025 Editorial Anti-Parasitic Stewardship: An Update in the Indian Setting Aditya Kundu, Ujjala Ghoshal* [PDF]          [FULL TEXT] Letter to Editor Post-Mortem Sepsis and Post-Mortem Diagnostic Anti-Microbial Stewardship Eeshan Pawar, Aswini Chandran, Diksha Chhabra, Arneet Arora, Sagar Khadanga* [PDF]          [FULL TEXT] Original Article MICs of Ciprofloxacin, Cefuroxime,

Other specific DSP article suggested by Editorial Board Development of a Comprehensive Program for the Early Diagnosis and Treatment of Severe Infections in a Tertiary Hospital in Spain. DOI: 10.1093/ofid/ofaf532 Authors: Martin-Gutierrez G et al   Abstract   Background: To assess the impact of the rapid diagnosis and treatment of severe infections (rDTSI) program on diagnostic

Other specific DSP article suggested by Editorial Board Clinical Pathway Revision Increases Amoxicillin Monotherapy and 5-Day Durations of Therapy for Pediatric Community-Acquired Pneumonia in the Emergency Department and Urgent Care: A Quality Improvement Initiative. DOI: 10.1016/j.annemergmed.2025.07.021 Authors:Weber MJ et al   Abstract   Study objective: The American Academy of Pediatrics recommends 5-day amoxicillin monotherapy as first-line treatment for